OSCR

TDP-43: [GU]-ardian of the transcriptome.

Overview

  1. Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD USA
  2. Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD USA
  3. Present Address: Allen Institute, WA Seattle, USA
  4. Medical Scientist Training Program, Johns Hopkins School of Medicine, Baltimore, MD USA
Institutions: Johns Hopkins University (United States); Johns Hopkins Medicine (United States); Allen Institute (United States); Johns Hopkins Hospital (United States)
Journal: Molecular neurodegeneration, volume 21, issue 1, article 34
Dates: received 9 January 2026; accepted 14 April 2026; published online 14 May 2026
Type: Review · Language: English
License: CC BY
Identifiers: DOI 10.1186/s13024-026-00944-2 · PMID 42135847 · PMCID PMC13343711 · OpenAlex W7161114406
Open access: gold, a free copy (OpenAlex)
Categories: genetics / omics (modality), human (organism), other condition (population), cellular / molecular (subfield)
MeSH: DNA-Binding Proteins*, Neurodegenerative Diseases*, Transcriptome*, Animals, Humans (* major topic)
Topic: Amyotrophic Lateral Sclerosis Research (Clinical Neurology, Medicine), according to OpenAlex
Funding: National Science Foundation (DGE2139757)
Citations: cited by 1 paper (Europe PMC); 670 references in the paper

Abstract

TDP-43 is a ubiquitously expressed, primarily nuclear DNA/RNA-binding protein implicated in neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer’s disease (AD). In this review, we examine the structure and regulation of TDP-43, how these features influence its localization and functional activity, and how their disruption may contribute to disease. Among TDP-43’s diverse functions, splicing repression of nonconserved RNA sequences termed cryptic exons has emerged as especially central to human disease. TDP-43 nuclear depletion and cytoplasmic aggregation are well-established pathological features in affected neurons and glia of neurodegenerative diseases, and accumulating evidence suggests that loss of TDP-43-mediated splicing repression occurs presymptomatically in disease. Advances in RNA-sequencing have enabled systematic identification of cryptic exon inclusion as a sensitive marker of TDP-43 dysfunction. Here, we synthesize current knowledge of TDP-43 biology and curate datasets from human tissues and experimental models, focusing on cryptic splicing to provide a resource for leveraging cryptic exon biology to better understand, detect, and target TDP-43 dysfunction.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

Data sharing is not applicable as no datasets were generated or analyzed in the article.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 5 authors, 5 MeSH terms, 1 funder, 667 references.

Cite

This paper

Sinha, I. R., Atkinson, A. L., Irwin, K. E., Ling, J. P., & Wong, P. C. (2026). TDP-43: [GU]-ardian of the transcriptome. Molecular neurodegeneration, 21(1), 34. https://doi.org/10.1186/s13024-026-00944-2

BibTeX

@article{sinha2026tdp,
author = {Sinha, Irika R and Atkinson, Abigail L and Irwin, Katherine E and Ling, Jonathan P and Wong, Philip C},
title = {{TDP-43: [GU]-ardian of the transcriptome}},
journal = {Molecular neurodegeneration},
year = {2026},
month = may,
volume = {21},
number = {1},
pages = {34},
publisher = {BMC},
issn = {1750-1326},
doi = {10.1186/s13024-026-00944-2},
url = {https://doi.org/10.1186/s13024-026-00944-2},
pmid = {42135847},
pmcid = {PMC13343711}
}

RIS

TY - JOUR
AU - Sinha, Irika R
AU - Atkinson, Abigail L
AU - Irwin, Katherine E
AU - Ling, Jonathan P
AU - Wong, Philip C
TI - TDP-43: [GU]-ardian of the transcriptome
T2 - Molecular neurodegeneration
J2 - Mol Neurodegener
PY - 2026
DA - 2026/05/14
VL - 21
IS - 1
SP - 34
SN - 1750-1326
PB - BMC
DO - 10.1186/s13024-026-00944-2
UR - https://doi.org/10.1186/s13024-026-00944-2
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s13024-026-00944-2",
"type": "article-journal",
"title": "TDP-43: [GU]-ardian of the transcriptome",
"container-title": "Molecular neurodegeneration",
"author": [
{
"family": "Sinha",
"given": "Irika R"
},
{
"family": "Atkinson",
"given": "Abigail L"
},
{
"family": "Irwin",
"given": "Katherine E"
},
{
"family": "Ling",
"given": "Jonathan P"
},
{
"family": "Wong",
"given": "Philip C"
}
],
"container-title-short": "Mol Neurodegener",
"volume": "21",
"issue": "1",
"page": "34",
"DOI": "10.1186/s13024-026-00944-2",
"PMID": "42135847",
"PMCID": "PMC13343711",
"ISSN": "1750-1326",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s13024-026-00944-2",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
14
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41467-025-62004-5 [code]
Large-scale RNA-Seq mining reveals ciclopirox olamine induces TDP-43 cryptic exons.
Journal: Nature communications
In common: genetics / omics, other condition, cellular / molecular, 46 references, 3 authors
[2] doi:10.1186/s13024-024-00732-w [code]
Elevated nuclear TDP-43 induces constitutive exon skipping.
Journal: Molecular neurodegeneration
In common: cellular / molecular, 41 references, 3 authors
[3] doi:10.1016/j.celrep.2024.115205 [code]
Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy.
Journal: Cell reports
In common: other condition, cellular / molecular, 48 references
[4] doi:10.1242/dmm.049418 [code]
Transcriptional targets of amyotrophic lateral sclerosis/frontotemporal dementia protein TDP-43 - meta-analysis and interactive graphical database.
Journal: Disease models & mechanisms
In common: genetics / omics, other condition, cellular / molecular, 43 references
[5] doi:10.1016/j.celrep.2024.115113
TDP43 autoregulation gives rise to dominant negative isoforms that are tightly controlled by transcriptional and post-translational mechanisms.
Journal: Cell reports
In common: other condition, cellular / molecular, 42 references
[6] doi:10.1371/journal.pbio.3003662
A quantitative cell-based reporter links TDP-43 aggregation and dysfunction to define pathogenic mechanisms.
Journal: PLoS biology
In common: other condition, cellular / molecular, 43 references
[7] doi:10.15252/embj.2022111719
Loss of TDP-43 oligomerization or RNA binding elicits distinct aggregation patterns.
Journal: The EMBO journal
In common: other condition, cellular / molecular, 40 references
[8] doi:10.26508/lsa.202503297 [code]
Aberrant NSUN1 activity connects m<sup>5</sup>C-RNA modification to TDP-43 neurotoxicity in ALS/FTD.
Journal: Life science alliance
In common: other condition, cellular / molecular, 39 references
[9] doi:10.1126/sciadv.ady0256
Isoform-specific steric zippers drive aberrant assembly and mislocalization of shortened TDP-43.
Journal: Science advances
In common: other condition, cellular / molecular, 37 references
[10] doi:10.1016/j.neuron.2026.01.018 [code]
DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay.
Journal: Neuron
In common: other condition, cellular / molecular, 36 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.